Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Thoracic 1Sarcoma 1Breast 1

Conditions

Sarcoma 54Dendritic Cell Sarcoma, Interdigitating 38Lymphoma 37Burkitt Lymphoma 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Large B-Cell, Diffuse 27Leukemia 27Lymphoma, Non-Hodgkin 25Recurrence 24Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Follicular 23Lymphoma, Mantle-Cell 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Acute 21Neuroectodermal Tumors, Primitive, Peripheral 19Hodgkin Disease 19Osteosarcoma 18Multiple Myeloma 18Myeloproliferative Disorders 17Central Nervous System Neoplasms 17Astrocytoma 17Neoplasms, Plasma Cell 16Leukemia, Myeloid, Chronic-Phase 16Rhabdomyosarcoma 15Leukemia, Myeloid, Accelerated Phase 15Blast Crisis 15Ovarian Neoplasms 14Neuroblastoma 13

Interventions

pembrolizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 3tislelizumab 2aflibercept 2Surveys and Questionnaires 2Radiotherapy 2Gene Expression Profiling 2Fentanyl 2Docetaxel 2Diet Therapy 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1toripalimab 1spartalizumab 1sargramostim 1rucaparib 1pegfilgrastim 1pazopanib 1olaparib 1milademetan 1entinostat 1durvalumab 1ciforadenant 1ceralasertib 1cemiplimab 1avelumab 1X-Rays 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Filgrastim × Sarcoma × Clear all
NCT07064018 2025-07-14

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

University of California, Irvine

Phase 1/2 Recruiting
67 enrolled
BreastGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡